January 18, 2022
RFA-FD-22-006 Conformance with the Egg Regulatory Program Standards (U2F) Clinical Trial Not Allowed
U.S. Food and Drug Administration (FDA)
This notice is to extend the Application Due Date for RFA-FD-22-006 Conformance with the Egg Regulatory Program Standards (U2F) Clinical Trial Not Allowed.
New Application Due Date(s)
February 28, 2022, by 11:59 PM Eastern Time
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the applications during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
Grants Management Specialist
Office if Acqusitions and Grants Services